Our resources

Regulatory submissions

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (2024)
Academic Trials
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (2024)
READ MORE →
 A Study of Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (2021)
FDA
A Study of Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (2021)
READ MORE →
 Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure (2021)
Academic Trials
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure (2021)
READ MORE →
 APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (2019)
FDA
APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (2019)
READ MORE →
 Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/​Neck Cancer Patients (2018)
FDA
Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/​Neck Cancer Patients (2018)
READ MORE →
 Dapagliflozin in Patients With Critical Illness (2022)
Academic Trials
Dapagliflozin in Patients With Critical Illness (2022)
READ MORE →
 Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading (2021)
Academic Trials
Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading (2021)
READ MORE →